Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

B. Riley Securities Maintains Buy on Diversified Healthcare, Raises Price Target to $4.5

Author: Benzinga Newsdesk | September 05, 2023 07:58am
B. Riley Securities analyst Bryan Maher maintains Diversified Healthcare (NASDAQ:DHC) with a Buy and raises the price target from $4 to $4.5.

Posted In: DHC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist